Literature DB >> 26555428

Intensity of anxiety is modified via complex integrative stress circuitries.

Justin P Smith1, Melissa A Prince2, Justin K Achua3, James M Robertson2, Raymond T Anderson4, Patrick J Ronan5, Cliff H Summers6.   

Abstract

Escalation of anxious behavior while environmentally and socially relevant contextual events amplify the intensity of emotional response produces a testable gradient of anxiety shaped by integrative circuitries. Apprehension of the Stress-Alternatives Model apparatus (SAM) oval open field (OF) is measured by the active latency to escape, and is delayed by unfamiliarity with the passageway. Familiar OF escape is the least anxious behavior along the continuum, which can be reduced by anxiolytics such as icv neuropeptide S (NPS). Social aggression increases anxiousness in the SAM, reducing the number of mice willing to escape by 50%. The apprehension accompanying escape during social aggression is diminished by anxiolytics, such as exercise and corticotropin releasing-factor receptor 1 (CRF1) antagonism, but exacerbated by anxiogenic treatment, like antagonism of α2-adrenoreceptors. What is more, the anxiolytic CRF1 and anxiogenic α2-adrenoreceptor antagonists also modify behavioral phenotypes, with CRF1 antagonism allowing escape by previously submissive animals, and α2-adrenoreceptor antagonism hindering escape in mice that previously engaged in it. Gene expression of NPS and brain-derived neurotrophic factor (BDNF) in the central amygdala (CeA), as well as corticosterone secretion, increased concomitantly with the escalating anxious content of the mouse-specific anxiety continuum. The general trend of CeA NPS and BDNF expression suggested that NPS production was promoted by increasing anxiousness, and that BDNF synthesis was associated with learning about ever-more anxious conditions. The intensity gradient for anxious behavior resulting from varying contextual conditions may yield an improved conceptualization of the complexity of mechanisms producing the natural continuum of human anxious conditions, and potential therapies that arise therefrom.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRF(1) receptors; Continuum; Exercise; Gradient; NPS; α(2) receptors

Mesh:

Substances:

Year:  2015        PMID: 26555428      PMCID: PMC4838407          DOI: 10.1016/j.psyneuen.2015.10.016

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

3.  Changes in markers of brain serotonin activity in response to chronic exercise in senior men.

Authors:  Michel O Melancon; Dominique Lorrain; Isabelle J Dionne
Journal:  Appl Physiol Nutr Metab       Date:  2014-06-23       Impact factor: 2.665

4.  Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.

Authors:  E Heyman; F-X Gamelin; M Goekint; F Piscitelli; B Roelands; E Leclair; V Di Marzo; R Meeusen
Journal:  Psychoneuroendocrinology       Date:  2011-10-24       Impact factor: 4.905

5.  Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.

Authors:  Yan-Ling Xu; Christine M Gall; Valerie R Jackson; Olivier Civelli; Rainer K Reinscheid
Journal:  J Comp Neurol       Date:  2007-01-01       Impact factor: 3.215

6.  Neuropeptide S interacts with the basolateral amygdala noradrenergic system in facilitating object recognition memory consolidation.

Authors:  Ren-Wen Han; Hong-Jiao Xu; Rui-San Zhang; Pei Wang; Min Chang; Ya-Li Peng; Ke-Yu Deng; Rui Wang
Journal:  Neurobiol Learn Mem       Date:  2013-11-06       Impact factor: 2.877

Review 7.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Adrenergic transmission facilitates extinction of conditional fear in mice.

Authors:  Christopher K Cain; Ashley M Blouin; Mark Barad
Journal:  Learn Mem       Date:  2004 Mar-Apr       Impact factor: 2.460

Review 9.  Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.

Authors:  Remo Guerrini; Severo Salvadori; Anna Rizzi; Domenico Regoli; Girolamo Calo'
Journal:  Med Res Rev       Date:  2010-09       Impact factor: 12.944

10.  Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment.

Authors:  Chang You; Huaibo Zhang; Amul J Sakharkar; Tara Teppen; Subhash C Pandey
Journal:  Int J Neuropsychopharmacol       Date:  2013-10-09       Impact factor: 5.176

View more
  13 in total

1.  Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Authors:  Clarissa D Staton; Jazmine D W Yaeger; Delan Khalid; Fadi Haroun; Belissa S Fernandez; Jessica S Fernandez; Bali K Summers; Tangi R Summers; Monica Sathyanesan; Samuel S Newton; Cliff H Summers
Journal:  Neuropharmacology       Date:  2018-09-18       Impact factor: 5.250

2.  Central noradrenergic activity affects analgesic effect of Neuropeptide S.

Authors:  Kei Jinushi; Tetsuya Kushikata; Takashi Kudo; Girolamo Calo; Remo Guerrini; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2017-11-11       Impact factor: 2.078

Review 3.  Curiosity as an approach to ethoexperimental analysis: Behavioral neuroscience as seen by students and colleagues of Bob Blanchard.

Authors:  Brandon L Pearson; Jacqueline N Crawley; David Eilam; Nathan S Pentkowski; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2016-03-24       Impact factor: 8.989

4.  Anxious behavior induces elevated hippocampal Cb2 receptor gene expression.

Authors:  James M Robertson; Justin K Achua; Justin P Smith; Melissa A Prince; Clarissa D Staton; Patrick J Ronan; Tangi R Summers; Cliff H Summers
Journal:  Neuroscience       Date:  2017-04-07       Impact factor: 3.590

5.  Contextual generalization of social stress learning is modulated by orexin receptors in basolateral amygdala.

Authors:  Jazmine D W Yaeger; Kevin T Krupp; Tangi R Summers; Cliff H Summers
Journal:  Neuropharmacology       Date:  2022-06-17       Impact factor: 5.273

Review 6.  Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.

Authors:  Cliff H Summers; Jazmine D W Yaeger; Clarissa D Staton; David H Arendt; Tangi R Summers
Journal:  Brain Res       Date:  2018-12-24       Impact factor: 3.252

7.  Neural and endocrine responses to social stress differ during actual and virtual aggressive interactions or physiological sign stimuli.

Authors:  Wayne J Korzan; Tangi R Summers; Cliff H Summers
Journal:  Behav Processes       Date:  2020-12-05       Impact factor: 1.777

Review 8.  Evolution of stress responses refine mechanisms of social rank.

Authors:  Wayne J Korzan; Cliff H Summers
Journal:  Neurobiol Stress       Date:  2021-04-21

Review 9.  Cardinal role of the environment in stress induced changes across life stages and generations.

Authors:  Terence Y Pang; Jazmine D W Yaeger; Cliff H Summers; Rupshi Mitra
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

10.  Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior.

Authors:  Jazmine D W Yaeger; Kevin T Krupp; Benjamin M Jacobs; Benard O Onserio; Brandon L Meyerink; Jacob T Cain; Patrick J Ronan; Kenneth J Renner; Ralph J DiLeone; Cliff H Summers
Journal:  Biol Psychiatry       Date:  2022-01-19       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.